Social media has become an important tool for pharmaceutical companies to raise brand awareness and assess the public’s appetite for its products. Some groups are also studying the effect of financial and charitable incentives to influence behavior. Now AstraZeneca (NYSE: AZN) has combined these in one website promoting national breast cancer awareness month. AstraZeneca division […]
Angel investment networks tend to stick to metropolitan cities on the East Coast and West Coast. Why? Most angels see themselves as philanthropic investors and want to invest locally. Startups tend to sprout in places that encourage entrepreneurship and reward it. Traditionally, that has been in cities on the coasts but that is beginning to […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In AstraZeneca’s (NYSE: AZN) statement outlining additional changes the drug maker will make to its global business to achieve scientific leadership this week, it underscored the magnitude with a few words. “Focus” was mentioned 11 times — a few times in bold. “Accelerate” was used eight times and “transform” got a few mentions too. But […]
AstraZeneca (NYSE:AZN) is revamping its research and development divisions to improve drug development by cutting 1,600 from its global operations and focusing R&D staff in three sites including Gaithersburg, Maryland. It plans to ditch its London headquarters in favor of a new $500 million center in Cambridge in the UK by 2016. By focusing on […]
Biotechnology company iBio (NYSE MKT: IBIO) with a plant-based platform to develop vaccines and therapeutics has formalized a collaboration agreement with a Texas-based life science company. A previous iteration of that company used iBio’s plant technology for a DARPA-backed large-scale production facility to develop vaccines and therapeutics using tobacco plants as part of “the GreenVax” […]
Research to develop artificial salivary glands to facilitate swallowing for throat cancer patients has brought a Delaware health system’s cancer research center a $2.5 million grant from the National Institutes of Health. Throat cancer patients receiving radiation therapy can suffer from a lack of saliva that prevents them from swallowing properly and from enjoying beverages […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
With my ears still ringing from July 4 fireworks, I was drawn to the handy infographic mapping out states’ positions on expanding their Medicaid programs for low-income residents to comply with the Affordable Care Act. With the recent U.S. Supreme Court decision, the Medicaid mandate was changed to require states to agree to expand their […]
Eli Lilly‘s (NYSE:LLY) rheumatoid arthritis treatment developed by drug developer Incyte (NASDAQ:INCY) using oral janus-associated kinases, or JAK, inhibitors, has produced positive phase 2b results, according to a company statement. The results were presented at the European League Against Rheumatism’s Annual European Congress of Rheumatology. The randomized double-blind, placebo-controlled, dose-ranging study, known as JADA, involved […]
A European Union regulatory committee’s recommendation to approve a drug developed by Incyte (NASDAQ:INCY) to treat the bone marrow disease myelofibrosis has triggered a $40 million milestone payment from Novartis (NYSE:NVS). The recommendation was made for Jakavi (ruxolitinib) by the European Medicines Agency’ Committee for Medicinal Products for Human Use. The EU regulatory body usually […]
AstraZeneca (NYSE:AZN) and Amgen (NYSE:AMGN) will collaborate on five monoclonal antibodies to treat inflammatory diseases in a move that could help AstraZeneca steer away from the patent cliff and put recent setbacks behind. The pharmaceutical companies will jointly develop and commercialize five Amgen drugs. AstraZeneca will pay an initial $50 million up front and shoulder […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Started in 2008 by one of the co-founders of PayPal, Yammer is a behind-the-firewall, institutional version of Facebook and has developed a base of 1,500 healthcare institutions and biotech companies in the U.S. and other countries, according to a Yammer spokeswoman.
AstraZeneca (NYSE:AZN) is cutting more than 7,300 jobs across its global operations as part of a restructuring move the pharmaceutical giant announced in its fourth-quarter earnings for 2012. A spokesman for the company confirmed the 7,300 in cuts spread over the next two years could impact some positions at its U.S. headquarters in Wilmington, Delaware. […]
Bristol-Myers Squibb (NYSE:BMY) and AstraZeneca’s (NYSE:AZN) jointly developed treatment for type 2 diabetes has been turned down by U.S. regulators until lingering questions over the diabetes drug’s benefits and risks are addressed. The U.S. Food and Drug Administration has requested additional clinical data on dapagliflozin to better assess the benefit-risk profile for the drug, including […]
iBio (NYSE:IBIO) is seeking to raise $10 million for its plant-based vaccine production in a public offering. The Newark, Delaware-based pharmaceutical company has priced 15,385,000 units at 65 cents per unit. Each unit includes one share of common stock and 0.75 of a warrant to purchase one share of common stock. The warrants will have an […]
Evozym Biologics, founded in 2009 by Antarctic research scientists at the University of Delaware and the Desert Research Institute, has raised $600,000 to fund business development and strategic partnerships for its gene discovery software and database business. Funding for the Lewes, Delaware company came from core investors, said Joseph Grzymski, the president and co-founder of […]